Cue Biopharma, Inc. CUE
At closeNov 13, 2026, 4:38 AM EST
Pre-market · Nov 13, 4:38 AM ET
- YTD
- +91.26%
- 1 year
- -12.67%
Discussion (202)
Sign in to join the discussion
$CUE this is just silly! ?
$CUE Looking forward to the virtual R&D day! Hopefully we get some promising news
$CUE what a ridiculous morning thus far… this is waaaaaay overdone.
$CUE Wild ride the past few days, but I’m here for it. While we really haven’t heard from OZ, it seems that he’s got CUE on the right track and the team is focused. I bet what we’ve seen is mostly all retail that drove this down yesterday… those that quickly jumped on the bandwagon and then jumped off… anyone who’s retail long or an institution would realize that anything less than $0.28 is below why the warrant holders purchased at and is less than cash on hand.
$CUE Reality of a Reverse Split… this stock is basically trading at cash around $0.28-$0.29 shares. If the price stays where it’s at and they do a massive reverse split, it’s STILL trading at basically cash on hand with a lot more positive information out about it. Needs to go up… would like to see this get into the $0.45-$0.50 range and hold it as the new bottom.
$CUE ? ? ?
$CUE Anyone know how the presentation went?!
$CUE I’ve got a feeling… ?
$CUE to present at the AAAAI Annual Meeting this Saturday!
$CUE Buying anywhere around $0.29 is essentially buying their 2026 cash on hand and incentives. The company has strong partnerships, proven leadership who’ve made corrective action, and a developing portfolio of therapy’s… seems like they are getting more active on the PR front, especially on X, and have the game board set to rally… time to execute.
